How will AI revolutionise oncology?
3 min
Available until 04/02/2027
With 58,000 cases annually, breast cancer remains the leading cause of cancer death for women. However, the AI-powered software RlapsRisk—developed by the Gustave Roussy Institute and a Franco-American startup—offers new hope by accurately predicting relapse risks through advanced medical image analysis.
Image
F. Balland
Editing
K. Mamoun
Journalist
P. Bon
Country
France
Germany
Year
2026
You may also like
ARTE Europe Weekly
Can Europe defend itself against the threat from drones?
ARTE Europe Weekly
Should Europe get tougher on young offenders?
ARTE Europe Weekly
Is Football Having an Identity Crisis?
ARTE Europe Weekly
How do we save a museum sector in crisis?
ARTE Europe Weekly
The rise of ‘tweakments’: How Botox has hit the mainstream
ARTE Europe Weekly
Is Europe failing to protect its LGBTQ+ community?
ARTE Europe Weekly
Return hubs: the answer or a step too far?
ARTE Europe Weekly
Does Europe still need cash?
Ukraine: Russian drone pilots hunt farmers
The most viewed videos on ARTE
NotInitialized